| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | Chief Accounting Officer | Common Stock | 128,294 | $9,641,294 | $75.15 | 12 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | 12 Dec 2025 | 1 | -$150,525 | 4 | Chief Accounting Officer | 16 Dec 2025, 18:24 |
| BBIO | BridgeBio Pharma, Inc. | 08 Dec 2025 | 1 | -$148,520 | 4 | Chief Accounting Officer | 10 Dec 2025, 07:53 |
| BBIO | BridgeBio Pharma, Inc. | 16 Nov 2025 | 1 | -$317,411 | 4 | Chief Accounting Officer | 18 Nov 2025, 19:23 |
| BBIO | BridgeBio Pharma, Inc. | 16 Aug 2025 | 1 | -$245,361 | 4 | Chief Accounting Officer | 19 Aug 2025, 19:40 |
| BBIO | BridgeBio Pharma, Inc. | 07 Aug 2025 | 1 | -$45,440 | 4 | Chief Accounting Officer | 11 Aug 2025, 18:29 |
| BBIO | BridgeBio Pharma, Inc. | 16 May 2025 | 1 | -$161,755 | 4 | Chief Accounting Officer | 20 May 2025, 17:05 |
| BBIO | BridgeBio Pharma, Inc. | 02 May 2025 | 1 | -$39,509 | 4 | Chief Accounting Officer | 06 May 2025, 16:45 |
| BBIO | BridgeBio Pharma, Inc. | 19 Mar 2025 | 1 | $0 | 4 | Chief Accounting Officer | 21 Mar 2025, 18:03 |
| BBIO | BridgeBio Pharma, Inc. | 19 Feb 2025 | 0 | $0 | 3 | Chief Accounting Officer | 27 Feb 2025, 20:22 |